63/120
2.6 / 5 stars
All 120 Win/Lose results shown below
BMI Roast Me summary
BADGER METER INC (BMI). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseBMI / S&P -2.28% / 15.20% |
LoseBMI / S&P 0.80% / 15.00% |
LoseBMI / S&P -6.75% / 50.40% |
| 2026-Q10/3 |
LoseBMI / S&P -12.42% / -4.33% |
LoseBMI / S&P 5.19% / 11.30% |
LoseBMI / S&P -2.42% / 27.70% |
| 2025-Q41/3 |
LoseBMI / S&P -2.10% / 2.65% |
WinBMI / S&P 10.90% / 9.00% |
LoseBMI / S&P 13.24% / 13.40% |
| 2025-Q32/3 |
LoseBMI / S&P -26.94% / 8.12% |
WinBMI / S&P 12.11% / 4.61% |
WinBMI / S&P 16.63% / 13.45% |
| 2025-Q23/3 |
WinBMI / S&P 28.93% / 10.94% |
WinBMI / S&P 11.82% / 4.83% |
WinBMI / S&P 19.84% / 10.63% |
| 2025-Q12/3 |
LoseBMI / S&P -10.16% / -4.27% |
WinBMI / S&P 15.08% / 4.98% |
WinBMI / S&P 30.84% / 10.57% |
| 2024-Q42/3 |
LoseBMI / S&P -2.73% / 2.41% |
WinBMI / S&P 17.48% / 5.25% |
WinBMI / S&P 34.71% / 6.15% |
| 2024-Q33/3 |
WinBMI / S&P 17.40% / 5.89% |
WinBMI / S&P 20.25% / 5.89% |
WinBMI / S&P 39.45% / 6.11% |
| 2024-Q23/3 |
WinBMI / S&P 15.32% / 4.28% |
WinBMI / S&P 24.00% / 5.38% |
WinBMI / S&P 46.18% / 5.12% |
| 2024-Q12/3 |
LoseBMI / S&P 5.00% / 10.56% |
WinBMI / S&P 25.07% / 5.71% |
WinBMI / S&P 42.80% / 5.59% |
| 2023-Q42/3 |
LoseBMI / S&P 7.50% / 11.69% |
WinBMI / S&P 24.40% / 6.81% |
WinBMI / S&P 38.94% / 7.78% |
| 2023-Q33/3 |
WinBMI / S&P -2.34% / -3.27% |
WinBMI / S&P 20.67% / 7.52% |
WinBMI / S&P 27.88% / -5.03% |
| 2023-Q23/3 |
WinBMI / S&P 21.33% / 8.74% |
WinBMI / S&P 17.87% / 9.50% |
WinBMI / S&P 19.63% / -8.57% |
| 2023-Q13/3 |
WinBMI / S&P 11.94% / 7.50% |
WinBMI / S&P 13.95% / 10.77% |
WinBMI / S&P 15.71% / -15.69% |
| 2022-Q43/3 |
WinBMI / S&P 18.24% / 7.56% |
WinBMI / S&P 11.95% / 11.88% |
WinBMI / S&P 8.65% / -17.99% |
| 2022-Q33/3 |
WinBMI / S&P 14.48% / -4.88% |
WinBMI / S&P 14.99% / 13.47% |
WinBMI / S&P 16.49% / -1.41% |
| 2022-Q22/3 |
LoseBMI / S&P -18.66% / -16.10% |
WinBMI / S&P 14.59% / 13.71% |
WinBMI / S&P 14.66% / 11.04% |
| 2022-Q11/3 |
LoseBMI / S&P -6.24% / -4.60% |
WinBMI / S&P 19.52% / 15.97% |
LoseBMI / S&P 19.32% / 42.23% |
| 2021-Q41/3 |
LoseBMI / S&P 5.55% / 11.03% |
WinBMI / S&P 18.72% / 15.00% |
LoseBMI / S&P 23.08% / 96.40% |
| 2021-Q32/3 |
WinBMI / S&P 3.27% / 0.58% |
WinBMI / S&P 14.50% / 10.77% |
LoseBMI / S&P 16.17% / 69.42% |
| 2021-Q21/3 |
LoseBMI / S&P 5.63% / 8.55% |
WinBMI / S&P 12.22% / 6.58% |
LoseBMI / S&P 19.37% / 51.81% |
| 2021-Q11/3 |
LoseBMI / S&P -0.89% / 6.17% |
WinBMI / S&P 1.55% / -1.06% |
LoseBMI / S&P 6.02% / 7.39% |
| 2020-Q43/3 |
WinBMI / S&P 44.20% / 12.15% |
WinBMI / S&P 0.22% / -3.72% |
WinBMI / S&P 4.97% / -33.42% |
| 2020-Q32/3 |
LoseBMI / S&P 4.19% / 8.93% |
WinBMI / S&P -0.17% / -2.04% |
WinBMI / S&P 5.70% / -27.10% |
| 2020-Q21/3 |
LoseBMI / S&P 17.70% / 20.54% |
LoseBMI / S&P -1.80% / -0.46% |
WinBMI / S&P 29.03% / -27.11% |
| 2020-Q12/3 |
WinBMI / S&P -17.23% / -19.60% |
LoseBMI / S&P -1.23% / 3.47% |
WinBMI / S&P 56.60% / -14.75% |
| 2019-Q42/3 |
WinBMI / S&P 21.25% / 9.07% |
LoseBMI / S&P -2.10% / 5.36% |
WinBMI / S&P 69.47% / 2.99% |
| 2019-Q31/3 |
LoseBMI / S&P -9.74% / 1.70% |
LoseBMI / S&P -1.05% / 5.02% |
WinBMI / S&P 92.68% / 0.21% |
| 2019-Q22/3 |
WinBMI / S&P 7.59% / 4.30% |
LoseBMI / S&P 1.95% / 6.64% |
WinBMI / S&P 25.25% / 8.65% |
| 2019-Q10/3 |
LoseBMI / S&P 13.35% / 13.65% |
LoseBMI / S&P 6.82% / 8.12% |
LoseBMI / S&P -7.02% / 14.29% |
| 2018-Q41/3 |
WinBMI / S&P -6.81% / -13.52% |
LoseBMI / S&P 7.78% / 9.05% |
LoseBMI / S&P -20.17% / 18.23% |
| 2018-Q31/3 |
WinBMI / S&P 18.79% / 7.71% |
LoseBMI / S&P 6.79% / 10.21% |
LoseBMI / S&P -28.07% / 19.06% |
| 2018-Q20/3 |
LoseBMI / S&P -4.91% / 3.43% |
LoseBMI / S&P 5.11% / 9.03% |
LoseBMI / S&P -15.38% / 14.46% |
| 2018-Q10/3 |
LoseBMI / S&P -1.11% / -0.76% |
LoseBMI / S&P 2.81% / 7.68% |
LoseBMI / S&P 0.88% / 12.46% |
| 2017-Q40/3 |
LoseBMI / S&P -2.17% / 6.64% |
LoseBMI / S&P 2.20% / 7.03% |
LoseBMI / S&P 7.21% / 13.82% |
| 2017-Q31/3 |
WinBMI / S&P 23.32% / 4.48% |
LoseBMI / S&P 0.62% / 5.68% |
LoseBMI / S&P BMI unavailable / 17.57% |
| 2017-Q21/3 |
WinBMI / S&P 8.76% / 3.09% |
LoseBMI / S&P -1.10% / 4.83% |
LoseBMI / S&P BMI unavailable / 17.74% |
| 2017-Q10/3 |
LoseBMI / S&P -0.22% / 6.07% |
LoseBMI / S&P 0.04% / 3.67% |
LoseBMI / S&P BMI unavailable / 13.32% |
| 2016-Q42/3 |
WinBMI / S&P 10.62% / 3.82% |
WinBMI / S&P 4.25% / 2.09% |
LoseBMI / S&P BMI unavailable / 7.05% |
| 2016-Q31/3 |
LoseBMI / S&P -7.91% / 3.85% |
WinBMI / S&P 6.78% / 0.20% |
LoseBMI / S&P BMI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | BMI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -25.23% | 20.78% |
| Annualized return | -25.23% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | BMI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 32.15% | 83.14% |
| Annualized return | 5.73% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | BMI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 350.11% | 319.30% |
| Annualized return | 16.23% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vontier Corp (VNT) | United States | $4.178B | 11.23 |